| scholarly article | Q13442814 |
| P50 | author | Juan Carlos Hernandez-Boluda | Q60608180 |
| P2093 | author name string | David Navarro | |
| Carlos Solano | |||
| Concepción Gimeno | |||
| Marisa Calabuig | |||
| Nuria Tormo | |||
| María A Clari | |||
| María J Remigia | |||
| José C Latorre | |||
| Santiago Furió | |||
| P2860 | cites work | Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection | Q47980476 |
| Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. | Q51175881 | ||
| CMV monitoring using blood cells and plasma: a comparison of apples with oranges? | Q54558030 | ||
| The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. | Q54563527 | ||
| Quantitative real-time PCR with automated sample preparation for diagnosis and monitoring of cytomegalovirus infection in bone marrow transplant patients. | Q54726609 | ||
| Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation | Q57181379 | ||
| Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay | Q62066497 | ||
| Quantitative analysis of cytomegalovirus load using a real-time PCR assay. | Q64953713 | ||
| Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study | Q71775777 | ||
| Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation | Q72047313 | ||
| Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients | Q73335173 | ||
| Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture | Q73536032 | ||
| Cytomegalovirus quantification in plasma by an automated real-time PCR assay | Q79828069 | ||
| Active CMV disease does not always correlate with viral load detection | Q80237555 | ||
| Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients | Q80525527 | ||
| Definitions of cytomegalovirus infection and disease in transplant recipients | Q28210268 | ||
| A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation | Q33264234 | ||
| Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients | Q33967345 | ||
| Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation | Q33968089 | ||
| Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. | Q33974273 | ||
| Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay | Q34437840 | ||
| Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients | Q34439235 | ||
| Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma | Q34991529 | ||
| Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification | Q35913862 | ||
| Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. | Q36597473 | ||
| Detection of human cytomegalovirus DNA by real-time quantitative PCR. | Q39459320 | ||
| Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. | Q39462006 | ||
| Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation | Q39462398 | ||
| Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation | Q39466867 | ||
| Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients | Q39626863 | ||
| High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay. | Q39664628 | ||
| Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients | Q40507092 | ||
| Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection | Q40762485 | ||
| Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus | Q40833879 | ||
| Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specim | Q41915452 | ||
| Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients | Q43652322 | ||
| Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction | Q43973082 | ||
| Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation | Q44012475 | ||
| Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation | Q44214552 | ||
| A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients | Q44448250 | ||
| Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia | Q44618517 | ||
| Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients | Q46801387 | ||
| Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation | Q46889368 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytomegaloviral disease | Q2076966 |
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | 3311-3318 | |
| P577 | publication date | 2008-08-27 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients | |
| P478 | volume | 46 |
| Q45347053 | Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting. |
| Q51609961 | Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation. |
| Q42269481 | An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting. |
| Q41041259 | Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait |
| Q42244257 | Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. |
| Q26768568 | Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis |
| Q35139837 | Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients |
| Q42275611 | Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients |
| Q37101524 | Cytomegalovirus in Plasma of Acute Coronary Syndrome Patients |
| Q43735414 | Cytomegalovirus infection in pediatric allogenic hematopoietic stem cell transplantation. A single center experience. |
| Q84028370 | Cytomegalovirus infection in solid organ transplantation |
| Q26801802 | Cytomegalovirus infection in transplant recipients |
| Q37240436 | Cytomegalovirus-Productive Infection Is Associated With Acute Coronary Syndrome |
| Q40343812 | Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients |
| Q40522033 | Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma |
| Q37546310 | Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value? |
| Q41128262 | Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients. |
| Q42246332 | Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients. |
| Q36306393 | Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation |
| Q41172989 | Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia. |
| Q42282848 | Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients. |
| Q43912964 | Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression |
| Q41104283 | Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation |
| Q44793485 | Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients. |
| Q44050947 | Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients |
| Q38805253 | Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients |
| Q39486182 | Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting. |
| Q45925385 | Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients |
| Q42242953 | Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients |
| Q44714539 | Management of cytomegalovirus infection in haemopoietic stem cell transplantation |
| Q41373726 | Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources. |
| Q40182511 | Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leukocytes and with quantitative PCR. |
| Q34057379 | Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients. |
| Q96647455 | New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention |
| Q38097119 | Opportunistic viral infections in intestinal transplantation |
| Q35940701 | Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients |
| Q45398742 | Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center. |
| Q40880905 | Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood |
| Q42977950 | Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients |
| Q93083451 | Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation |
| Q26740588 | Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia |
| Q54423747 | Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR. |
| Q45372130 | Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation |
| Q83225298 | Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT |
| Q33785773 | Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. |
| Q33591729 | Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. |
| Q42242868 | Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT. |
| Q54422897 | Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. |
| Q54357205 | [Cytomegalovirus. Pathological-anatomical manifestations and detection methods]. |
Search more.